OUR SERVICES

Regulatory Affairs, Drug Development, Pharmacovigilance, Medical Writing, Pricing & Reimbursement, Market Access

MORE

ABOUT US

Partner of many pharmaceutical companies, managing hundreds of multi-task projects, on a worldwide-scale

MORE

EVENTS

Discover next events

MORE

BLOG

ALL POSTS
Jun, 03 2020

MARKET ACCESS – AIFA GUIDELINE FOR THE D...

The Italian HTA Agency (AIFA) has published the first guideline in order to harmonize the structure and the requirements for a cor...

READ
May, 22 2020

MARKET ACCESS – UPDATED CRITERIA FOR...

An update for the increase of prices of medicinal products reimbursed by the Italian NHS has recently been provided by AIFA. &n...

READ
May, 22 2020

REGULATORY AFFAIRS – COVID-19: EMA I...

Due to the current COVID-19 pandemic, EMA has taken lots of initiatives (EMA/213341/2020) to accelerate the development support an...

READ
RPN @regulatorypharmanet - JUN 4

CONTACT US

Our experts are available to help you with any question you might have








 
I accept THE PRIVACY POLICY